Laura E. Bianchi

Varese, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Area postrema syndrome and painful tonic spasms as initial manifestations of Neuromyelitis optica spectrum disorder in a 72-year-old female: a case report.

Area postrema syndrome and painful tonic spasms as initial manifestations of Neuromyelitis optica spectrum disorder in a 72-year-old female: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 11, 2023

Spectral domain optical coherence tomography findings in myotonic dystrophy.

Spectral domain optical coherence tomography findings in myotonic dystrophy.

Journal: Neuromuscular disorders : NMD

Published: April 09, 2019

Correction to: Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.

Correction to: Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: December 08, 2018

Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.

Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 01, 2018

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.

Journal: International journal of molecular sciences

Published: October 31, 2016

Erratum to: Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Erratum to: Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Journal: Journal of neurology

Published: February 26, 2016

Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1).

Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1).

Journal: Biochimica et biophysica acta

Published: July 08, 2015

An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy.

An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy.

Journal: Neuroepidemiology

Published: June 26, 2015

Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Journal: Journal of neurology

Published: June 17, 2015

Author response.

Author response.

Journal: Neurology

Published: September 20, 2014

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Journal: Neurology

Published: August 06, 2014

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Journal: Neurology

Published: January 22, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026